SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Guofu Li, Jiahong Fu, Yang Zhao, Kaiqiang Ji, Ting Luan, Bin Zang, Alpha-Lipoic Acid Exerts Anti-Inflammatory Effects on Lipopolysaccharide-Stimulated Rat Mesangial Cells via Inhibition of Nuclear Factor Kappa B (NF-κB) Signaling Pathway, Inflammation, 2015, 38, 2, 510

    CrossRef

  2. 2
    Sumon Roy, Dongjoon Kim, Cristina Hernández, Rafael Simó, Sayon Roy, Beneficial Effects of Fenofibric Acid on Overexpression of Extracellular Matrix Components, COX-2, and Impairment of Endothelial Permeability Associated with Diabetic Retinopathy, Experimental Eye Research, 2015,

    CrossRef

  3. 3
    Haidy E. Zidan, Noha A. Rezk, Amr Abd Almohsen Alnemr, Amany M. Abd el Ghany, COX-2 gene promoter DNA methylation status in eutopic and ectopic endometrium of Egyptian women with endometriosis, Journal of Reproductive Immunology, 2015, 112, 63

    CrossRef

  4. 4
    Katarzyna Kaminska, Cezary Szczylik, Fei Lian, Anna M Czarnecka, The role of prostaglandin E2 in renal cell cancer development: future implications for prognosis and therapy, Future Oncology, 2014, 10, 14, 2177

    CrossRef

  5. 5
    X Wang, L Zhang, A O'Neill, B Bahamon, D C Alsop, J W Mier, S N Goldberg, S Signoretti, M B Atkins, C G Wood, R S Bhatt, Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts, British Journal of Cancer, 2013, 108, 2, 319

    CrossRef

  6. 6
    Ji Won Lee, Jeong Hwan Park, Ja Hee Suh, Kyung Han Nam, Ji-Young Choe, Hae Yoen Jung, Ji Yoen Chae, Kyung Chul Moon, Cyclooxygenase-2 Expression and Its Prognostic Significance in Clear Cell Renal Cell Carcinoma, Korean Journal of Pathology, 2012, 46, 3, 237

    CrossRef

  7. 7
    Sarfraz Ali, Qiqin Yin-Goen, Timothy V. Johnson, Wei Han, Nicole A. Johnson, Wayne B. Harris, Fray F. Marshall, Andrew N. Young, Viraj A. Master, Adeboye O. Osunkoya, Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients, Tumor Biology, 2011, 32, 2, 375

    CrossRef

  8. 8
    Wan-Chen Huang, Chee-Yin Chai, Wei-Chiao Chen, Ming-Feng Hou, Yu-Shiuan Wang, Yi-Ching Chiu, Shiang-Ru Lu, Wen-Chang Chang, Suh-Hang Hank Juo, Jaw-Yuan Wang, Wei-Chiao Chang, Histamine regulates cyclooxygenase 2 gene activation through Orai1-mediated NFκB activation in lung cancer cells, Cell Calcium, 2011, 50, 1, 27

    CrossRef

  9. 9
    Xianmin Bu, Chenghai Zhao, Xianwei Dai, Involvement of COX-2/PGE2Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer, Gastroenterology Research and Practice, 2011, 2011, 1

    CrossRef

  10. 10
    Tetsuyuki Takahashi, Hirohisa Ogawa, Keisuke Izumi, Hisanori Uehara, The soluble EP2 receptor FuEP2/Ex2 suppresses endometrial cancer cell growth in an orthotopic xenograft model in nude mice, Cancer Letters, 2011, 306, 1, 67

    CrossRef

  11. 11
    Hyo Song Kim, Won Seog Kim, Se Hoon Park, Chul Won Jung, Han Yong Choi, Hyun Moo Lee, Seong Soo Jeon, Hongil Ha, In Gyu Hwang, Seungkoo Lee, Ho Yeong Lim, Molecular biomarkers for advanced renal cell carcinoma: Implications for prognosis and therapy, Urologic Oncology: Seminars and Original Investigations, 2010, 28, 2, 157

    CrossRef

  12. 12
    Jun Qin, Jianlin Yuan, Ling Li, Heliang Liu, Rongliang Qin, Weijun Qin, Baoqi Chen, He Wang, Kaichun Wu, In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells, Biomedicine & Pharmacotherapy, 2009, 63, 3, 241

    CrossRef

  13. 13
    N. Shinohara, A. Kumagai, K. Kanagawa, S. Maruyama, T. Abe, A. Sazawa, K. Nonomura, Multicenter Phase II Trial of Combination Therapy with Meloxicam, a COX-2 Inhibitor, and Natural Interferon-  for Metastatic Renal Cell Carcinoma, Japanese Journal of Clinical Oncology, 2009, 39, 11, 720

    CrossRef

  14. 14
    Sinan Sozen, Serhat Gurocak, Ozlem Erdem, Cenk Acar, Yakup Kordan, Gulen Akyol, Turgut Alkibay, Cyclooxygenase-2 expression: Does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma?, International Urology and Nephrology, 2008, 40, 2, 295

    CrossRef

  15. 15
    Elizabeth P. Ryan, Timothy P. Bushnell, Alan E. Friedman, Irfan Rahman, Richard P. Phipps, Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells, Cancer Immunology, Immunotherapy, 2008, 57, 3, 347

    CrossRef

  16. 16
    John A Taylor III, Carol Pilbeam, Andrew Nisbet, Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies, Expert Review of Anticancer Therapy, 2008, 8, 7, 1125

    CrossRef

  17. 17
    Ayhan Dirim, Asuman Nihan Haberal, Mehmet Resit Goren, Mehmet Ilteris Tekin, Levent Peskircioglu, Beyhan Demirhan, Hakan Ozkardes, VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value, International Urology and Nephrology, 2008, 40, 4, 861

    CrossRef

  18. 18
    Monika K. Krzyzanowska, Ian F. Tannock, Gina Lockwood, Jennifer Knox, Malcolm Moore, Georg A. Bjarnason, A phase II trial of continuous low-dose oral cyclophosphamide and celecoxib in patients with renal cell carcinoma, Cancer Chemotherapy and Pharmacology, 2007, 60, 1, 135

    CrossRef

  19. 19
    Maria Rosaria Raspollini, Gian Luigi Taddei, Cyclooxygenase-2: A novel target in human solid tumors, Current Oncology Reports, 2007, 9, 2, 96

    CrossRef

  20. 20
    Takashi Ishigami, Katsuhiro Uzawa, Morihiro Higo, Hitomi Nomura, Kengo Saito, Yoshikuni Kato, Dai Nakashima, Masashi Shiiba, Hiroki Bukawa, Hidetaka Yokoe, Tetsuya Kawata, Hisao Ito, Hideki Tanzawa, Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells, International Journal of Cancer, 2007, 120, 10
  21. 21
    Yen-Chuan Ou, Chi-Rei Yang, Chen-Li Cheng, Shue-Ling Raung, Yu-Yeh Hung, Chun-Jung Chen, Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT, European Journal of Pharmacology, 2007, 563, 1-3, 49

    CrossRef

  22. 22
    Konstantinos Giannitsas, Agelis Konstantinopoulos, Petros Perimenis, Non-steroidal anti-inflammatory drugs in the treatment of genitourinary malignancies: focus on clinical data, Expert Opinion on Investigational Drugs, 2007, 16, 11, 1841

    CrossRef

  23. 23
    Annie Pfohl-Leszkowicz, Richard A. Manderville, Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans, Molecular Nutrition & Food Research, 2007, 51, 1
  24. 24
    Taku-Kemal Sasaki, Toshichika Takita, Contribution of polyunsaturated fatty acids to Shiga toxin cytotoxicity in human renal tubular epithelium-derived cells, Biochemistry and Cell Biology, 2006, 84, 2, 157

    CrossRef

  25. 25
    M. Ugur Mungan, Duygu Gurel, A. Erdem Canda, Burcin Tuna, Kutsal Yorukoglu, Ziya Kirkali, Expression of COX-2 in Normal and Pyelonephritic Kidney, Renal Intraepithelial Neoplasia, and Renal Cell Carcinoma, European Urology, 2006, 50, 1, 92

    CrossRef

  26. 26
    Brian I. Rini, Vivian Weinberg, Sarah Dunlap, Alexandra Elchinoff, Nancy Yu, Robert Bok, Jeffery Simko, Eric J. Small, Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma, Cancer, 2006, 106, 3
  27. 27
    Stephen Hiscox, Wen Go Jiang, Kathrin Obermeier, Kathryn Taylor, Liam Morgan, Raj Burmi, Denise Barrow, Robert I. Nicholson, Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of β-catenin phosphorylation, International Journal of Cancer, 2006, 118, 2
  28. 28
    Q CHEN, N SHINOHARA, T ABE, T HARABAYASHI, K NONOMURA, IMPACT OF CYCLOOXYGENASE-2 GENE EXPRESSION ON TUMOR INVASIVENESS IN A HUMAN RENAL CELL CARCINOMA CELL LINE, The Journal of Urology, 2004, 172, 6, 2153

    CrossRef

  29. 29
    Burcin Tuna, Kutsal Yorukoglu, Duygu Gurel, Ugur Mungan, Ziya Kirkali, Significance of COX-2 expression in human renal cell carcinoma, Urology, 2004, 64, 6, 1116

    CrossRef

  30. 30
    JÜRGEN BRIEGER, PETRA SCHROEDER, JAN GOSEPATH, WOLF J. MANN, The Cyclooxygenase Inhibitor Flurbiprofen Reduces Radiation-Induced Angiogenic Growth Factor Secretion of Squamous Cell Carcinoma Cell Lines, Annals of the New York Academy of Sciences, 2004, 1030, 1